Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7

Experimental Neurology

Volumn 142, Issue 1, 1996, Pages 14-28

  Bartus, R T ^a,b   Elliott, P J ^a   Dean, R L ^a   Hayward, N J ^a   Nagle, T L ^a   Huff, M R ^a   Snodgrass, P A ^a   Blunt, D G ^a  

^a ALKERMES INC   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ DERIVATIVE; BRADYKININ RECEPTOR AGONIST; CARBOPLATIN; CARMUSTINE; DEXTRAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BLOOD BRAIN BARRIER; BRAIN TUMOR; CELL LINE; CONTROLLED STUDY; FEMALE; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030296346     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0175     Document Type: Article

References (49)

1. 1. BARTUS, R. T., P. J. ELLIOTT, N. J. HAYWARD, R. L. DEAN, E. MCEWEN, AND S. K. FISHER. 1996. Bradykinin permeation of the BBB: Evidence for a sensitive auto-regulated, receptor-mediated system. Immunopharmacology 33: 270-278.
2. 2. BETZ, A. L. 1992. An overview of the multiple functions of the blood-brain barrier. In Bioavailability of Drugs to the Brain and the Blood-Brain Barrier (J. Frankenheim and R. M. Brown, Eds.), NIDA Drug Abuse Research Monograph Series 120, pp. 54-72. U.S. Government Printing Office, Washington, DC.
3. 3. BHOOLA, K. D., C. D. FIGUEROA, AND K. WORTHY. 1992. Bioregulation of kinins: Kallikreins, kininogens and kinases. Pharmacol. Rev. 44: 1-80.
4. 4. BLACK, K. L. 1995. Biochemical opening of the blood-brain barrier. Adv. Drug Rev. 15: 37-52.
5. 5. BLASI, F. 1993. Molecular mechanisms of protease-mediated tumor invasiveness. J. Surg. Oncol. Suppl. 3: 1-23.
6. 6. BRIGHTMAN, M. W., AND T. S. REESE. 1969. Junctions between intimately apposed cell membranes in the vertebrate brain. J. Cell. Biol. 40: 648-677.
7. 7. CURRAN, W. J., C. B. SCOTT, J. HORTON, J. S. NELSON, A. S. WEINSTEIN, A. J. FISCHBACH, C. H. CHANG, M. ROTMAN, S. O. ASBELL, R. E. KIRSCH, AND D. F. NELSON. 1993. Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J. Natl. Cancer Inst. 85: 704-710.
8. 8. DEAN, R. L., P. J. ELLIOTT, T. L. NAGLE, N. J. HAYWARD, R. E. MERCHANT, AND R. T. BARTUS. 1996. RMP-7 increases uptake of carboplatin into rat gliomas: Comparison of three cell lines. Proc. Am. Assoc. Cancer Res. 37(2063): 303.
9. 9. DEVITA, V. T. 1993. Principles of chemotherapy. In Cancer Principles and Practice of Oncology, (V. T. DeVita, S. Hellman, and S. A. Rosenberg, Eds.), 4th ed., pp. 276-292. Lippincott, Philadelphia.
10. 10. DOCTROW, S. R., S. M. ABELLEIRA, L. A. CURRY, et al. 1994. The bradykinin analog RMP-7 increases intracellular free calcium levels in rat brain microvascular endothelial cells. J. Pharmacol. Exp. Ther. 271: 229-237.
11. 11. EHRLICH, P. 1885. Das Sauerstoff-Bedurfnis des Organismus. Eine Farbenanalytische Studie. Hirschwald, Berlin.
12. 12. ELLIOTT, P. J., N. J. HAYWARD, R. L. DEAN, AND R. T. BARTUS. 1996. Dissociation of blood-brain barrier permeability and the hypotensive effects of the bradykinin B2 agonist, RMP-7. Immunopharmacology 33: 205-208.
13. 13. FRIDEN, P. M. 1993. Receptor-mediated transport of peptides and proteins across the blood-brain barrier. In The Blood-Brain Barrier: Cellular and Molecular Biology (W. M. Pardridge, Eds.), pp. 229-247. Raven Press, New York.
14. 14. GOLDMAN, E. E. 1913. Vitalfarbung am Zentralnervensystem. Abh. Press Akad. Wiss. Phys. Math. K1: 1-60.
15. 15. GROOTHIUS, D. R., J. R. FISCHER, G. LAPIN, D. D. BIGNER, AND N. A. VICK. 1982. Permeability of different experimental brain tumor models to horseradish peroxidase. J. Neuropathol. Exp. Neurol. 41: 164-185.
16. 16. GROUS, J. J., P. J. ELLIOTT, AND R. T. BARTUS. 1996. Development of RMP-7: A novel bradykinin agonist that increases delivery of chemotherapeutics to gliomas. In Adjuvant Therapy of Cancer, VIII (S. E. Salmon, Ed.), Lippincott-Raven, Philadelphia, In press.
17. 17. ELLIOTT, P. J., N. J. HAYWARD, M. R. HUFF, T. L. NAGLE, K. MATSUKADO, K. L. BLACK, AND R. T. BARTUS. 1996. Unlocking the blood-brain barrier: A role for RMP-7 in brain tumor therapy. Exp. Neurol. 141: 204-224.
18. 18. HIESIGER, E. M., S. B. GREEN, W. R. SHAPIRO, et al. 1995. Results of a randomized trial comparing intra-arterial cisplatin and intravenous PCNU for the treatment of primary brain tumors in adults: Brain Tumor Cooperative Group trial 8420A. J. Neurooncol. 25: 143-154.
19. 19. HIRANO, A., AND T. MATSUI. 1975. Vascular structures in brain tumors. Hum. Pathol. 6: 611-621.
20. 20. INAMURA, T., AND K. L. BLACK. 1994. Bradykinin selectively opens blood-tumor barrier in experimental brain tumors. J. Cereb. Blood Flow. Metab. 14: 862-870.
21. 21. INAMURA, T., T. NOMURA, R. T. BARTUS, AND K. L. BLACK. 1994. Intracarotid infusion of RMP-7, a bradykinin analog: A method for selective drug delivery to brain tumors. J. Neurosurg. 81: 752-758.
22. 22. KESSLER, M. J. 1989. Liquid Scintillation Analysis. Packard Publication 169-3052.
23. 23. LONG, D. M. 1970. Capillary ultrastructure and the blood-brain barrier in human malignant brain tumors. J. Neurosurg. 32: 127-144.
24. 24. MARTINS, M. A., C. P. PASQUALE, P. T. BOOZZA, P. M. R. SILVA, H. C. C. F. NETO, AND S. B. CORDEIRO. 1992. Homologous tachyphylaxis to bradykinin and its interference with allergic pathways in actively sensitized rats. Eur. J. Pharmacol. 220: 55-61.
25. 25. MATSUKADO, K., T. INAMURA, S. NAKANO, M. FUKUI, R. T. BARTUS, AND K. L. BLACK. 1996. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7. Neurosurgery, 39: 125-134.
26. 26. MUNOZ, C. M., AND L. M. F. LEE-LUNDBERG. 1992. Receptor-mediated internalization of bradykinin. J. Biol. Chem. 267: 303-309.
27. 27. NELSON, D. F., J. V. MCDONALD, L. W. LAPHAM, R. QAZI, AND P. RUBIN. 1992. Central nervous system tumors. In Clinical Oncology (R. Rubin, S. McDonald, R. Qazi, Eds.), pp. 617-644. Saunders, Philadelphia.
28. 28. NOMURA, T., T. INAMURA, AND K. L. BLACK. 1994. Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors. Brain Res. 659: 62-66.
29. 29. OHNO, K., K. O. PETTIGREW, AND S. I. RAPOPORT. 1978. Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am. J. Physiol. 253: H299-H307.
30. 30. OLDENDORF, W. H., M. E. CORNFORD, AND W. J. BROWN. 1981. Some unique ultrastructural characteristics of rat brain capillaries. In Cerebral Microcirculation and Metabolism (J. Cervos-Navarro and E. Fritschka, Eds.), pp. 9-15. Raven Press, New York.
31. 31. PELLEGRINO, L. J., A. S. PELLEGRINO, AND A. J. CUSHMAN. 1986. A Stereotaxic Atlas of the Rat Brain, 2nd ed. Plenum, New York.
32. 32. RADHAKRISHNAN, K., N. I. BOHNEN, AND L. T. KURLAND. 1994. Epidemiology of brain tumors. In Brain Tumors: A Comprehensive Text (R. A. Morantz and J. W. Walsh, Eds.), Dekker, New York.
33. 33. RAPOPORT, S. I. 1985. A model for brain edema. In Brain Edema, Proceedings of the Sixth International Symposium (Y. Inaba, I. Klatzo, and M. Spatz, Eds.), pp. 59-71. Springer-Verlag, Berlin.
34. 34. RAYMOND, J. J., D. M. ROBERTSON, AND H. B. DINSDALE. 1986. Pharmacological modification of bradykinin induced breakdown of the blood-brain barrier. Can. J. Physiol. Pharmacol. 13: 214-220.
35. 35. REESE, T. S., AND M. J. KARNOVSKY. 1967. Fine structure localization of a blood-brain barrier to exogenous peroxidase. J. Cell. Biol. 34: 207-217.
36. 36. REGOLI, D., AND J. BARABE. 1980. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32: 1-46.
37. 37. ROBINSON, P. J., AND S. I. RAPOPORT. 1987. Size selectivity of blood-barrier permeability at various times after osmotic opening. Am. J. Physiol. 253: R459-R466.
38. 38. ROSENBLUM, W. L. 1965. Cerebral microcirculation: A review emphasizing the interrelationship of local blood flow and neuronal function. Angiology 16: 485-507.
39. 39. SANOVICH, E., R. T. BARTUS, P. F. FRIDEN, R. L. DEAN, H. Q. LE, AND M. W. BRIGHTMAN. 1995. Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7. Brain Res. 705: 125-135.
40. 40. SENGER, D. R., L. VAN DE WATER, L. F. BROWN, J. A. NAGY, K. T. YEO, T. K. YEO, B. BERSE, R. W. JACKMAN, A. M. DVORAK, AND H. F. DVORAK. 1993. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 12: 303-324.
41. 41. SHIBATA, S. 1989. Ultrastructure of capillary walls in human brain tumors. Acta Neuropathol. 78: 561-571.
42. 42. STRAUB, J. A., A. AKIYAMA, AND P. PARMAR. 1994. In vitro plasma metabolism of RMP-7. Pharm. Res. 11: 1673-1676.
43. 43. VAN MEIR, E. G. 1995. Cytokines and tumors of the central nervous system. Glia 15: 264-288.
44. 44. WAHL, M., L. SCHILLING, A. UNTERBERG, AND A. BAETHMANN. 1993. Mediators of vascular and parenchymal mechanism in secondary brain damage. Acta Neurochir. Suppl. 57: 64-72.
45. 45. ZIYLAN, Y. Z., J. M. LEFAUCONNIER, G. BERNARD, AND J. M. BOURRE. 1988. Effect of dexamethasone on transport of alpha-aminoisobutyric acid and sucrose across the blood-brain barrier. J. Neurochem. 51: 1338-1342.
46. 3H]insulin after osmotic opening in the rat. Exp. Neurol. 79: 845-857.
47. 47. ZIYLAN, Y. Z., P. J. ROBINSON, AND S. I. RAPOPORT. 1984. Blood-brain barrier permeability to sucrose and dextran after osmotic opening. Am. J. Physiol. 247: R634-R638.
48. 48. ZLOKOVIC, B. V., J. G. MCCOMB, L. PERLMUTTER, M. H. WEISS, AND H. DAVSON. 1992. Neuroactive peptides and amino acid at the blood-brain barrier: Possible implications for drug abuse. In: Bioavailability of Drugs to the Brain and the Blood-Brain Barrier (J. Frankenheim, and R. M. Brown, Eds.), NIDA Drug Abuse Research Monograph Series 120, pp. 54-72.
49. 49. ZLOKOVIC, B. V. 1995. Cerebrovascular permeability to peptides: Manipulations of transport systems at the blood-brain barrier. Pharm. Res. 12: 1395-1406.